Author:
Nagpal Seema,Riess Jonathan,Wakelee Heather
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference44 articles.
1. Cancer Facts and Figures 2012. Available at http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf . Accessed 29 May 2012.
2. Eichler AF, Wang DL, Joshi VA, et al. EGFR mutation status and survival after diagnosis of brain metastasis in non-small cell lung cancer. J Clin Oncol. 2012;5(Suppl(May 20)):7542.
3. Chen AM, Jahan TM, Jablons DM, et al. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain. Cancer. 2007;109(8):1668–75.
4. Oechsle K, Lange-Brock V, Kruell A, et al. Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis. J Cancer Res Clin Oncol. 2010;136(11):1729–35.
5. Kesari S, Batchelor TT. Leptomeningeal metastases. Neurol Clin. 2003;21(1):25–66.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献